Cargando…

Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()

Detalles Bibliográficos
Autores principales: Boixeda, R., Campins, L., Juanola, J., Force, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519711/
https://www.ncbi.nlm.nih.gov/pubmed/32836322
http://dx.doi.org/10.1016/j.rceng.2020.07.004
_version_ 1783587625235382272
author Boixeda, R.
Campins, L.
Juanola, J.
Force, L.
author_facet Boixeda, R.
Campins, L.
Juanola, J.
Force, L.
author_sort Boixeda, R.
collection PubMed
description
format Online
Article
Text
id pubmed-7519711
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
record_format MEDLINE/PubMed
spelling pubmed-75197112020-09-28 Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment() Boixeda, R. Campins, L. Juanola, J. Force, L. Rev Clin Esp (Barc) Correspondence Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2020-11 2020-09-26 /pmc/articles/PMC7519711/ /pubmed/32836322 http://dx.doi.org/10.1016/j.rceng.2020.07.004 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Boixeda, R.
Campins, L.
Juanola, J.
Force, L.
Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
title Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
title_full Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
title_fullStr Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
title_full_unstemmed Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
title_short Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
title_sort is chronic obstructive pulmonary disease a protective factor in sars-cov-2 infection? the importance of bronchodilator treatment()
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519711/
https://www.ncbi.nlm.nih.gov/pubmed/32836322
http://dx.doi.org/10.1016/j.rceng.2020.07.004
work_keys_str_mv AT boixedar ischronicobstructivepulmonarydiseaseaprotectivefactorinsarscov2infectiontheimportanceofbronchodilatortreatment
AT campinsl ischronicobstructivepulmonarydiseaseaprotectivefactorinsarscov2infectiontheimportanceofbronchodilatortreatment
AT juanolaj ischronicobstructivepulmonarydiseaseaprotectivefactorinsarscov2infectiontheimportanceofbronchodilatortreatment
AT forcel ischronicobstructivepulmonarydiseaseaprotectivefactorinsarscov2infectiontheimportanceofbronchodilatortreatment
AT ischronicobstructivepulmonarydiseaseaprotectivefactorinsarscov2infectiontheimportanceofbronchodilatortreatment